result question manag
august
summari result
anoth poor quarter lfl sale growth come factset
consensu expect gross margin declin reason beyond us
result guid gross margin expans ebit margin declin
yoy ep ahead consensu expect primarili due tax
highlight believ price drag organ sale growth
turn posit end fiscal year
revis ep primarili due tax
activist activist easi solut estim ebit gener
maintain under-perform rate target price move
question manag
guid tax headwind fx commod yet price
expect turn posit end year clear evid price
environ structur chang
exan bnpp estim thomson reuter consensu list currenc dividend reinvest yearli averag price fy end
date time london time invest recommend finalis may differ date time broad dissemin
websit appendix analyst certif import disclosur non-u research analyst disclosur
result question
summari result
anoth poor quarter lfl sale growth come
factset consensu expect shape deliveri much in-lin
expect although note achiev except strong volum
growth fabric except neg price
coupl fact made refer flat organ sale
would rather suggest competit fabric arena
turn toward bottom-lin gross margin declin reason
beyond us result guid gross margin expans ebit
margin declin yoy ep ahead consensu
expect primarili due tax
figur outlin main element releas rel
consensu expect
figur summari result rel expect
varianc
 guid follow
organ sale growth note factset consensu current
all-in sale growth in-lin includ headwind fx
ep growth mid-point consensu current
ep growth
tax underli tax rate
product better
return dividend common share
highlight main newsworthi item may easili glean
quick read releas
price price expect drag organ sale growth
turn posit end fiscal year unusu sever categori
industri wait commod cost build certain level take
price noth fundament chang take increas pamper
north america yesterday announc take list price
bounti charmin puff north america bounti charmin effect
octob puff year whole expect
organ sale growth driven volum growth
market highlight believ market growth remain
 need grow littl faster achiev object
retail inventori like continu reduc e-commerc grow
financi underli tax rate guidanc also
reflect gs go forward expect like close interest cost non-
oper incom around point drag core ep growth
fd share count around lower merck kgaa consum
healthcar acquisit expect complet around end calendar year
china china improv
includ gs categori china hold
grow share babi sale share trend improv sequenti
year busi achiev mid-singl digit sale growth pamper
return overal share leadership mainland olay deliv quarter
double-digit organ growth china around gs china sale
e-commerc media spend digit margin
chines busi improv tax tax basi
e-commerc e-commerc sale grew last year reach
nearli approach sale increas yoy
come increas gs market share aggreg
similar e-commerc off-lin differ country/categori
fabric us fabric volum growth year japan fabric
record fy organ sale growth europ achiev
organ sale growth second consecut year achiev
consecut month market share growth
sk-ii grown consecut quarter averag rate
whole achiev growth
media work media spend increas sale made
good progress deliv appropri standard measur effort
around complet help cut wast reduc media cost
around believ bring media back in-hous
reduc number agenc fix retain use resourc as-
need basi save advertis agenc product
cost past year come major save
like reinvest
growth suffer neg impact brazilian trucker strike
saudi arabia iran algerian import ban inflat egypt/nigeria organ sale
across market reduc organ sale growth around act
dampen group organ sale growth trade inventori reduct act
drag top countri grew organ sale
turkey india achiev strong double-digit growth japan achiev mid-singl digit
growth mexico china grew
shape organ sale growth like strongest
profit progress reflect fact price expect improv
cours year expect neg becom
posit product save like build year progress year
whole ebit margin expect expand
optim gs increas optim driven market share trend
posit total compani june us trend
better fy trend largest market
groom gs global shave care share in-lin py braun
gain us male blade razor valu share move declin
nearli flat us male shave care post volum
growth look forward aspir grow busi
environ remain difficult value-orient competitor expand us in-
store distribut harri on-lin competitor dsc expand europ
figur outlin revis previou ep estim
figur summari ep revis
varianc previou estim primarili relat incorpor
result modestli reduc futur tax rate
activist activist easi solut estim ebit
gener develop market
rate target price
maintain under-perform rate previous argu see fxing
estim best valu price-to-earnings appli methodolog
revis ep estim revis target price
question manag
guid tax headwind fx commod yet
price expect turn posit end year clear evid
price environ structur chang
organ sale growth vs guidanc
differ
given share count tax interest non-oper item like
much wash earn guid all-in sale flat top-
end ep growth guidanc appear assum except strong
margin expans pleas talk driver behind
pleas explain drove mark improv beauti
margin simpli function sale leverag
activist nelson peltz recent comment idea reorganis
 seriou consider thought
price neg fabric drove neg price
fit categori strategi
report cnbc offer pfizer consum
healthcar unit aspir closer see
scope acquir asset due cours
groom busi materi impact third parti disrupt
look across remaind busi categori believ
vulner disrupt natur
would consid acquir adjac white-spac categori focu
upon exist categori
comment disruptor industri emerg
technolog insight hope may disrupt
comment call innov pipelin full year
pleas give insight import innov
hit market year
achiev gross margin expans guid
stage pleas explain lay behind comment stage
come way expect
pleas explain seemingli big delta
consolid us sale develop suggest retail scanner data
harri share extrapol nation mainstream retail
would implic us groom busi
within guidanc tax headwind fx commod
implicit assumpt wrt develop pulp cycl
pleas see overleaf revis segment sale profit loss account
fabric
babi feminin famili
profit taxat non-gaap
profit tax
tax pbt
tax pbt non-gaap
profit continu oper non-gaap
profit continu oper
profit discontinu oper
net profit attribut procter gambl
dividend payment prefer share
basic number share averag
fulli dilut number share averag
pay-out ratio basic non-gaap
dividend cover basic non-gaap
chg ebit non-gaap
depreci amortis
chg ebitda non-gaap
invest case valuat risk
activist activist easi solut estim ebit
gener develop market
valu price-to-earnings
upsid
risk would highlight includ possibl activist nelson peltz drive
posit chang anticip
downsid
risk would highlight includ possibl stock continu de-rat
investor increasingli question abil reignit organ sale growth
cross mikheil omanadz jeff stent heidi vesterinen author contributor report herebi certifi view express report
accur reflect person view compani compani secur discuss report part compens
directli indirectli relat specif recommend view express research report
research analyst name involv prepar research report research analyst exan limit exan sa associ person
exan inc thu regist qualifi research analyst financi industri regulatori author finra new york stock
exchang nyse non-u analyst subject nasd rule nyse rule restrict commun subject compani
public appear trade secur held research analyst account
exan sa regul autorit de march financi amf franc exan limit authoris regul financi conduct author
unit kingdom exan inc regul finra secur exchang commiss unit state
research analyst respons prepar report receiv compens base upon variou factor includ overal firm revenu may
research analyst respons prepar report member household may relationship compani cover
research report describ number disclosur tabl immedi indic disclosur appli research
analyst respons prepar research report
research analyst respons prepar report member his/her household has/hav financi interest secur subject
company/i indic previou tabl
research analyst respons prepar report member his/her household serv offic director advisori board member
subject company/i indic previou tabl
research analyst respons prepar report receiv compens subject company/i indic previou tabl
exan sa exan limit exan inc collect exan may relationship compani cover research report describ
number disclosur tabl immedi indic disclosur appli exan relationship subject company/i
exan benefici own class common equiti secur subject company/i
exan manag co-manag offer equiti secur subject company/i past month
exan receiv compens invest bank servic subject company/i past month invest bank servic
exan regard subject company/i exan distributor underwrit equiti secur offer managed-or co-manag bnp
pariba bnp pariba manag co-manag offer equiti secur subject company/i
exan expect receiv intend seek compens invest bank servic subject company/i next month
exan sa and/or exan limit are/i market maker and/or liquid provid secur subject company/i
exan inc receiv compens product servic invest bank servic subject company/i past month
exan inc invest bank servic client relationship subject company/i past month
exan inc non-invest bank securities-rel client relationship subject company/i past month
exan inc non-securities-rel servic relationship subject company/i past month
exan inc market maker secur subject company/i
exan benefici own least long short posit subject company/i
section report research summari target price rate remov present subject company/i prior distribut
sole purpos verifi accuraci factual statement
follow present section report subject compani conclus amend
commit transpar potenti conflict interest bnp pariba
bnp pariba bnpp hold materi ownership interest variou exan entiti exan bnpp enter agreement maintain
independ exan research report bnpp research report publish brand name exan bnp pariba nevertheless sake
transpar separ identifi potenti conflict interest bnpp regard company/ cover research document
bnpp may relationship compani cover research report describ number disclosur tabl immedi
indic disclosur appli bnpp relationship subject company/i
bnpp benefici own class common equiti secur subject company/i
bnpp manag co-manag offer equiti secur subject company/i past month
bnpp act advisor public offer involv subject company/i past month
bnpp receiv compens invest bank servic subject company/i past month
bnpp expect receiv intend seek compens invest bank servic subject company/i next month
member senior bnpp manag member board subject compani
bnpp benefici own least long short posit subject company/i
